MOSCOW (Reuters) – Russia’s RDIF sovereign wealth fund said on Monday it had agreed with Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V vaccine against COVID-19 in China.
RDIF said the two sides were committed to a long-term partnership in vaccine production.
(Reporting by Anastasia Teterevleva and Maxim Rodionov; Writing by Gabrielle Tétrault-Farber; Editing by Edmund Blair)
